Why Colfax Got the Axe Today — Down 16%

What happened

Investors in Annapolis Junction, Md.-based Colfax Corporation (NYSE: CFX) are watching their stock get chopped — down 16.4% as of 11:45 a.m. EST — after the diversified industrial technology company announced a $3.15 billion deal to buy DJO Global from its private-equity owner, Blackstone, this morning.

Better known as a maker of heavy-duty centrifugal and axial fans, gas compressors, and equipment for cutting and welding steel, Colfax is now expanding into the field of “orthopedic devices, software and services” with this acquisition — and investors aren’t particularly happy about that.

Legs only of a woman wearing a foot brace and using crutches.

Colfax enters a brave new world of orthopedics — and its first step is a doozy. Image source: Getty Images.

So what

Why not? Well, there’s the obvious fear: that Colfax may be overpaying. In its press release describing the acquisition, Colfax notes that it will be paying $3.15 billion cash to acquire DJO and its $1.2 billion revenue stream. (Hint: Colfax doesn’t actually have $3.15 billion in cash lying around. According to S&P Global Market Intelligence data, it’s got barely $285 million — and $1.1 billion in long-term debt.)

There’s also the possibility investors are concerned that “orthopedics” aren’t exactly in this company’s wheelhouse. Investors may worry that in its effort to accelerate revenue growth (currently stuck in the low single digits), Colfax may be falling into a diworsification trap.

Now what

Addressing both these concerns in one go, Colfax advised in its press release that it is, in fact, “committed to reducing leverage and restoring balance sheet flexibility near-term.” To that end, the company “will explore strategic options for our Air and Gas Handling business.” In other words, Colfax plans to exit one business as it enters a different one — and use the proceeds from selling its air and gas handling business to help pay for its purchase of DJO.

Even so, management says it will need to use $100 million of its cash on hand, draw upon its “credit facilities,” issue new debt, and probably issue and sell “$500 to $700 million from a contemplated offering of equity or equity-linked securities” in order to make this deal happen.

Investors can be forgiven for thinking that all this is quite a high price to pay for Colfax to completely revamp its business model.

10 stocks we like better than Colfax

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now… and Colfax wasn’t one of them! That’s right — they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of November 14, 2018

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.









Referenced Symbols: CFX

Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.

Wealth Empire Newsletter
Register now for free updates and alerts

Subscribe By

Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.